As an acquired disease analogous to ADH1, acquired hypoparathyroidism, including immune-checkpoint inhibitor-related hypoparathyroidism, has been reported to be caused by activating autoantibodies against CaSR (29–34). This evidence concerns the gene ADH1A and hypoparathyroidism.